IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents

<< Previous Issue

Jul 2004 (Vol: 2004, Issue: 49)

Next Issue >>

Section: Company Profile
Sereno SA Published: 4 Jul-2004
By: Business Review Editor
Abstract Fulltext:
Section: Distribution & Marketing
Abbott Acquires Remaining Rights to Trandolapril from Aventis Published: 4 Jul-2004
By: Business Review Editor
Abstract Fulltext:
Section: Licensing
CuraGen Licenses TopoTarget’s HDAC Inhibitor Published: 4 Jul-2004
By: Business Review Editor
Abstract Fulltext:
Section: Mergers & Acquisitions
UCB Tenders US$2.7 B Offer to Acquire Celltech Published: 4 Jul-2004
By: Business Review Editor
Abstract Fulltext:
Section: Research & Development
Yamanouchi and Pfizer Streamline Partnership for Japan Published: 4 Jul-2004
By: Business Review Editor
Abstract Fulltext:
MorphoSys and Novartis Sign Antibody Agreement Published: 4 Jul-2004
By: Business Review Editor
Abstract Fulltext:

PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.

Login

Username:

Password:

Keep me logged in